Minireviews
Copyright ©The Author(s) 2021.
World J Gastroenterol. May 28, 2021; 27(20): 2576-2585
Published online May 28, 2021. doi: 10.3748/wjg.v27.i20.2576
Figure 1
Figure 1 Organs of human body (different from lung and liver) in which angiotensin-converting enzyme 2 was detected, the main site of expression and the possible coronavirus disease 2019 related symptoms/complications are reported in the corresponding columns. COVID-19: Coronavirus disease 2019; ACE2: Angiotensin-converting enzyme 2.
Figure 2
Figure 2 The putative mechanisms inducing liver injury in the course of coronavirus disease 2019 are reported in the left side of the figure (? = controversial data on the specific mechanism). The right part describes the possible outcome according to patient baseline liver condition. NAFLD: Non-alcoholic fatty-liver-disease; COVID-19: Coronavirus disease 2019.